With researchers the world over racing against time to develop a treatment for covid-19, Israel on Monday said that scientists at the Israel Institute of Biological Research have successfully developed a monoclonal antibody that has the potential to “neutralize" the SARS-CoV2 virus.
In a statement, Israel’s defence ministry said that the country’s premier biological laboratory has completed the development phase of the covid-19 antibody.
However, it did not share any scientific literature on the subject or information on an extensive evaluation in the laboratory. “I’m proud of the Biological Institute staff who have made a major breakthrough," said defence minister Naftali Bennett, adding that the “antibody can neutralize the virus within